HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Muscle Biopsy

A muscle biopsy is a medical procedure in which a small sample of muscle tissue is extracted for diagnostic purposes. This minimally invasive procedure is typically performed to investigate and understand various muscle-related conditions, such as muscle weakness, pain, or inflammation. The collected tissue is then examined under a microscope to assess its structure, composition, and any abnormalities present. The biopsy process involves a local anesthetic to numb the area before a small incision is made to access the muscle. Alternatively, a needle biopsy may be employed, where a thin needle is inserted into the muscle to obtain a tissue sample. The choice of technique depends on the specific clinical scenario and the targeted muscle. Muscle biopsies are instrumental in identifying and diagnosing a range of muscular disorders, including muscular dystrophies, inflammatory myopathies, and metabolic myopathies. The findings from the biopsy help healthcare professionals tailor treatment plans and interventions to address the underlying cause of the patient's symptoms. Despite being a valuable diagnostic tool, muscle biopsies are not without risks. Potential complications include bleeding, infection, or nerve damage at the biopsy site. However, these complications are relatively rare, and the benefits of obtaining crucial diagnostic information often outweigh the associated risks. In summary, a muscle biopsy is a medical procedure that provides crucial insights into the nature of various muscular disorders. It plays a vital role in guiding accurate diagnoses and tailoring appropriate treatment strategies to improve the overall management of muscle-related conditions.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp